Nov 17, 2020 / 02:40PM GMT
Biren N. Amin - Jefferies LLC, Research Division - MD and Senior Equity Research Analyst
Welcome, everyone, to the Jefferies London Virtual Healthcare Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to introduce our next company. We have Neurocrine Biosciences, Kevin Gorman, their CEO; Matt Abernethy, CFO. And I guess Matt raided my closet and found a similar shirt this morning. So thanks for coordinating on this, Matt.
Matthew C. Abernethy - Neurocrine Biosciences, Inc. - CFO
Yes. No problem. I forgot my glasses at home, but we -- you at least have hair, and I don't. So that's one thing I'll never have again. So thanks for hosting us, and wish we were in London. It's such a beautiful time of the year. But Kevin and I are looking forward to spending time with you today.
Questions and Answers:
Biren N. Amin - Jefferies LLC, Research Division - MD and Senior Equity Research AnalystGreat. So let's just talk big picture. I think most investors can say that so far the
Trustpilot
